Search CDR Applicant’s Status

Search for a trainee based upon last name or email address:


First Name: Bhanu

Last Name: Priya

Email: bhanupriyaraghu@gmail.com

Site Number/Institution: ICMR – National Institute of Epidemiology

Reason: Requirement of a Course or Fellowship

Lilly Specific Study (if applicable):

Application Date: September 26, 2023 at 3:12 am


First Name: Hariklia

Last Name: Vagias

Email: hariklia.vagias1@monash.edu

Site Number/Institution: Darby-704

Reason: * Lilly Rater Academy

Lilly Specific Study (if applicable): I5T-MC-AACI

Application Date: September 25, 2023 at 8:22 pm


First Name: JOY

Last Name: OGRADY

Email: jogrady9177@yahoo.com

Site Number/Institution: National Clinical Research

Reason: * Abbvie Rater Academy

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 6:15 pm


First Name: jerry

Last Name: flexman

Email: jerryef2@aol.com

Site Number/Institution: 234

Reason: * Abbvie Rater Academy

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 4:22 pm


First Name: jerry

Last Name: flexman

Email: jerryef2@aol.com

Site Number/Institution: 234

Reason: * Abbvie Rater Academy

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 3:59 pm


First Name: MARIA

Last Name: GARCIA MARTINEZ

Email: magarcia.mart@gmail.com

Site Number/Institution: HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA-IDIVAL

Reason: Other Trial Not Listed Above

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 3:36 pm


First Name: MARIA

Last Name: GARCIA MARTINEZ

Email: magarcia.mart@gmail.com

Site Number/Institution: HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA-IDIVAL

Reason: * Abbvie Rater Academy

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 3:34 pm


First Name: Patricia

Last Name: Delgado

Email: patriciam.delgado@gmail.com

Site Number/Institution: K2 Medical Tampa

Reason: * Roche AD Digital POC Study

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 2:27 pm


First Name: Michael

Last Name: Rosenbloom

Email: mrosenbl@uw.edu

Site Number/Institution: University of Washington

Reason: * A3/A45 Study: Protocol BAN2401-G000-303

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 1:26 pm


First Name: Adriana

Last Name: Lasanta-Bondy

Email: adriana.lasanta-bondy@adventhealth.com

Site Number/Institution: 129 AdventHealth

Reason: Other Trial Not Listed Above

Lilly Specific Study (if applicable):

Application Date: September 25, 2023 at 12:46 pm